Malignant neoplasm of the thyroid gland - Ionising radiation to the thyroid gland Factor
Last reviewed for CCPS 18 July 2006.
Investigative Documents
Preliminary questions [35895]
there is some evidence that a dose of ionising radiation to the thyroid gland, from internal deposition of radioactive nuclides, may be a factor in the development of the condition under consideration.25191 the veteran's malignant neoplasm of the thyroid gland is a papillary, follicular or anaplastic thyroid carcinoma.
the veteran has received a dose of ionising radiation to the thyroid gland, from internal deposition of radioactive nuclides, at some time.35897 — the veteran has established the causal connection between the dose of ionising radiation to the thyroid gland and VEA service for the clinical onset of malignant neoplasm of the thyroid gland.
35898 — the veteran has established the causal connection between the dose of ionising radiation to the thyroid gland and operational service for the clinical onset of malignant neoplasm of the thyroid gland.
or
35899 — the veteran has established the causal connection between the dose of ionising radiation to the thyroid gland and eligible service for the clinical onset of malignant neoplasm of the thyroid gland.
Clinical onset and operational service [35898]
the veteran has received a cumulative equivalent dose of at least 0.05 Sievert of ionising radiation to the thyroid gland, from internal deposition of radioactive nuclides, where this dose was accumulated at least five years before the clinical onset of the condition under consideration. the veteran received the dose of ionising radiation to the thyroid gland, from internal deposition of radioactive nuclides, for an illness or injury which is identifiable. as a consequence of the identified illness or injury, the veteran received a cumulative equivalent dose of at least 0.05 Sievert of ionising radiation to the thyroid gland, from internal deposition of radioactive nuclides, where this dose was accumulated at least five years before the clinical onset of the condition under consideration.35905 — the identified illness or injury, for which the veteran received a dose of ionising radiation to the thyroid gland, from internal deposition of radioactive nuclides, is causally related to operational service.
Clinical onset and eligible service [35899]
35903 — the veteran has received a dose of ionising radiation to the thyroid gland, from internal deposition of radioactive nuclides, satisfying the exposure and age requirements for malignant neoplasm of the thyroid gland in Balance of Probability cases.
the veteran has received a cumulative equivalent dose of at least 0.1 Sievert of ionising radiation to the thyroid gland, from internal deposition of radioactive nuclides, where this dose was accumulated at least five years before the clinical onset of the condition under consideration and when aged less than 20 years.or
35902 the veteran has received a cumulative equivalent dose of at least 0.5 Sievert of ionising radiation to the thyroid gland, from internal deposition of radioactive nuclides, where this dose was accumulated at least ten years before the clinical onset of the condition under consideration.
35904 the veteran received the dose of ionising radiation to the thyroid gland, from internal deposition of radioactive nuclides, for an illness or injury which is identifiable.
as a consequence of the identified illness or injury, the veteran received a dose of ionising radiation to the thyroid gland, from internal deposition of radioactive nuclides, satisfying the exposure and age requirements for malignant neoplasm of the thyroid gland in Balance of Probability cases.35906 — the identified illness or injury, for which the veteran received a dose of ionising radiation to the thyroid gland, from internal deposition of radioactive nuclides, is causally related to eligible service.